GSK2578215A 25 mg | 99.81%
TargetMol
GSK2578215A
Search Results
RI-1 100 mg | 99.92%
TargetMol
RI-1
RI-1 25 mg | 99.92%
TargetMol
RI-1
RI-1 2 mg | 99.92%
TargetMol
RI-1
Wnt-C59 25 mg | 99.56%
TargetMol
Wnt-C59(C59) is a highly effective and specific Wnt signaling antagonis with PORCN enzymatic activity.
More Information Supplier PageWnt-C59
GSK2578215A 200 mg | 99.81%
TargetMol
GSK2578215A
GSK2578215A 100 mg | 99.81%
TargetMol
GSK2578215A
Bioymifi 100 mg | Purity Not Available
TargetMol
Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.
More Information Supplier PageBioymifi
Bioymifi 50 mg | Purity Not Available
TargetMol
Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.
More Information Supplier PageBioymifi
Bioymifi 2 mg | Purity Not Available
TargetMol
Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.
More Information Supplier PageBioymifi